About Universitäts-Hautklinik Kiel
Clinical Trials at Universitäts-Hautklinik Kiel
During the past decade, Universitäts-Hautklinik Kiel conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universitäts-Hautklinik Kiel" #1 sponsor was "Amgen" with 1 trials, followed by "Cytavis Biopharma GmbH" with 1 trials
sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Michael Weichenthal" with 1 trials sponsored and "Sun Pharmaceutical Industries Limited"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitäts-Hautklinik Kiel"
#1 collaborator was "Dermatologic Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Universitäts-Hautklinik Kiel
According to Clinical.Site data, the most researched conditions in "Universitäts-Hautklinik Kiel" are
"Melanoma" (3 trials), "Basal Cell Carcinoma" (1 trials), "Hidradenitis Suppurativa" (1 trials), "Malignant Melanoma" (1 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "Universitäts-Hautklinik Kiel" in a lesser frequency.
Clinical Trials Intervention Types at Universitäts-Hautklinik Kiel
Most popular intervention types in "Universitäts-Hautklinik Kiel" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Adalimumab" (1 trials), "Apremilast" (1 trials), "Atezolizumab" (1 trials) and "Bermekimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitäts-Hautklinik Kiel
The vast majority of trials in "Universitäts-Hautklinik Kiel" are
7 trials for "All" genders.
Clinical Trials Status at Universitäts-Hautklinik Kiel
Currently, there are NaN active trials in "Universitäts-Hautklinik Kiel".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Universitäts-Hautklinik Kiel,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Universitäts-Hautklinik Kiel, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".